The homeopathic approach to symptom control in the cancer patient: a prospective observational study

Abstract

The aims of this study were to describe a population of patients with cancer referred for complementary therapies to an NHS homeopathic hospital, and to explore the homeopathic approach to symptom control and its impact on mood disturbance and quality of life. One hundred consecutive patients attending a designated research cancer clinic were seen for a consultation, lasting up to 60 min, and prescription of a homeopathic remedy. A maximum of three symptoms were identified and rated by the patient as a problem, using a numerical selfrating scale. The effect these symptoms have on daily life and overall sense of well being were recorded using similar scales. Patients completed the Hospital Anxiety and Depression Scale (HADS) and the European Organization for Research and Treatment in Cancer - Quality of Life Questionnaire - Core 30 (EORTC QLQ-30) at the initial consultation and at four to six consultations later. After this time, the patients completed a final assessment questionnaire asking about satisfaction with the homeopathic approach, how helpful they had found the approach for the targeted symptoms and what factors they felt may have contributed to the changes perceived. One hundred patients were entered into the study. Thirty-nine patients had metastatic disease. Nine patients were refusing conventional cancer treatments. The most common symptoms were pain, fatigue and hot flushes. Symptom scores for fatigue and hot flushes improved significantly over the study period but not for pain scores. Side effects included a transient worsening of symptoms in a few cases, which settled on stopping the remedy. Fiftytwo patients completed the study, and in those patients satisfaction was high, and 75% (n=38) rated the approach as helpful or very helpful for their symptoms. Results suggest that further research is warranted to explore the management of hot flushes in women with breast cancer and fatigue in the cancer diagnosis.

Keywords

complementary therapies fatigue homeopathy menopausal symptoms quality of life

Get full access to this article

View all access options for this article.

References

Ernst E , Cassileth BR . The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83: 777–782.

Rees RW , Feigel I , Vickers A , Zollman C , McGurk R , Smith C . Prevalence of complementary therapy use by women with breast cancer. a population-based survey. Eur J Cancer 2000; 3: 1359–1364.

Reilly DT , Taylor MA , McSharry C , Aitchison T . Is homeopathy a placebo response? Controlled trial of homeopathic potency, with pollen in hayfever as model. Lancet 1986; ii: 881–886.

Reilly D , Taylor MA , Beattie NG , et al. Is evidence for homeopathy reproducible? Lancet 1994; 344: 1601–1606.

Kleijnen J , Knipschild P , ter Riet G . Clinical trials of homeopathy. BMJ 1991; 302: 316–323.

Linde K , Clausius N , Ramirez G , et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834–843.

Downer SM , Cody MM , McCluskey P , et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994; 309: 86–89.

Clover A , Last P , Fisher P , Wright S , Boyle H . Complementary cancer therapy: a pilot study of patients, therapies and quality of life. Complementary Ther Med 1995; 3: 129–133.

Thompson E , Hicks F . Intrathecal baclofen and homeopathy for the treatment of painful muscle spasms associated with malignant spinal cord compression. Palliat Med 1998; 12: 119–121.

10.

Oberbaum M , Yaniv I , et al. A randomised controlled trial of the homeopathic medication TRAUMWEEL S in the treatment of chemotherapy induced stomatitis in children undergoing stem cell transplantation. Cancer 2001.

11.

Balzarini A , Felisi E , Martini A , De Conno F . Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopathy J 2000; 89: 8–12.

12.

Marticek R , et al. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther 2001; 7.

13.

Paterson C . Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ 1996; 312: 1016–1020.

14.

Paterson C , Britten N . In pursuit of patient-centred outcomes: a qualitative evaluation of the ‘Measure Yourself Medical Outcome Profile.’ J Health Serv Res Policy 2000; 5: 27–36.

15.

Burstein HJ , Gelber S , Guadagnoli E , Weeks JC . Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999; 340: 1733–1739.

16.

Curt G . Fatigue in cancer. BMJ 2001; 322: 1560–1560.

17.

Vogelzang NJ , et al. Patient, caregiver and oncologist perception of cancer related fatigue: results of tripartate assessment survey. Semin Haematol 1997; 34(suppl 2): 4– 12.

18.

Curt G , et al. Impact of cancer related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist 2000; 5: 353–360.

19.

Le Fevre P , et al. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 1999; 13: 399–407.

20.

Lydick E , Epstein RS . Interpretation of quality of life changes. Qual Life Res 1993; 2: 221–226.

21.

King MT . The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555–567.

22.

Osoba D , Rodrigues G , Myles J , Zee B , Pater J . Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139–144.

23.

Greenhalgh T , Hurwitz B . Why study narrative? BMJ 1999; 318: 48–50.